Still a big issue

Banks are making a killing on the insurer’s $21 bln rights issue. Yet the deep discount on the pricing sits ill with the fat fees. Investors may be appeased with juicy subunderwriting. But that shouldn’t stop UK competition watchdogs investigating underwriting as a priority.